Search Results

All (10)

Posts (8)

Other Pages (2)

10 results found for "Amgen"

Amgen to Acquire Chemocentryx for $4 Billion in Cash
August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ : AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered and cancer, today announced that the companies have entered into a definitive agreement under which Amgen
📰 GPCR Weekly News, January 1 to 7, 2024
Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen
📰 GPCR Weekly News, November 13 to 19, 2023
Abbreviated New Drug Application (ANDA) Litigation PostEra Announces a Research Collaboration with Amgen

Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
Rottapel is a Senior Scientist at the Princess Margaret Cancer Centre where he holds the Amgen Chair
Ep 53 with Dr. Timo De Groof
During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and